ecrin-mdr-crcClinical2015Colorectal cancerColorectal CancerInterventionalhttps://newmdr.ecrin.org/Study/2634755Japan10ECRIN MDRActive, not recruitingfalsePhase II clinical trial on systemic oxaliplatin chemotherapy plus molecular target therapy combined with hepatic arterial infusion (HAI) therapy for colorectal liver metastasesInterventions: Period of intervension: 8 cycles of chemotherapy, mainly for 6 months. Primary outcome(s): Two-year relative-free survival after liver surgery Overall survival Study Design: Single arm Non-randomized2015-10-152634755JPRN-UMIN000019466